Inlyta Interactions
There are 248 drugs known to interact with Inlyta (axitinib), along with 11 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 62 are major, 164 are moderate, and 22 are minor.
- View all 248 medications that may interact with Inlyta
- View Inlyta alcohol/food interactions (3)
- View Inlyta disease interactions (11)
Most frequently checked interactions
View interaction reports for Inlyta (axitinib) and the medicines listed below.
- acetaminophen / hydrocodone
- albuterol
- allopurinol
- amlodipine
- aspirin
- atorvastatin
- Bystolic (nebivolol)
- carvedilol
- CoQ10 (ubiquinone)
- Eliquis (apixaban)
- furosemide
- gabapentin
- hydralazine
- Keytruda (pembrolizumab)
- Lasix (furosemide)
- levothyroxine
- lisinopril
- loratadine
- lorazepam
- losartan
- metoprolol
- Metoprolol Tartrate (metoprolol)
- omeprazole
- ondansetron
- oxycodone
- prednisone
- prochlorperazine
- tamsulosin
- Vitamin D3 (cholecalciferol)
- Xgeva (denosumab)
Inlyta alcohol/food interactions
There are 3 alcohol/food interactions with Inlyta (axitinib).
Inlyta disease interactions
There are 11 disease interactions with Inlyta (axitinib) which include:
- hemorrhagic events
- cardiac failure
- GI perforation
- hepatic impairment
- hypertension
- proteinuria
- renal impairment
- RPL syndrome
- thromboembolism
- thyroid dysfunction
- lung toxicity
Report options
QR code containing a link to this page
More about Inlyta (axitinib)
- Inlyta consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
